Alaunos Therapeutics (TCRT) Competitors $3.48 -0.51 (-12.78%) Closing price 04:00 PM EasternExtended Trading$3.23 -0.25 (-7.18%) As of 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TCRT vs. CLSD, TAOX, HOTH, RENB, RVPH, CING, ABP, APLM, CTXR, and SYBXShould you be buying Alaunos Therapeutics stock or one of its competitors? The main competitors of Alaunos Therapeutics include Clearside Biomedical (CLSD), Synaptogenix (TAOX), Hoth Therapeutics (HOTH), Lunai Bioworks (RENB), Reviva Pharmaceuticals (RVPH), Cingulate (CING), Abpro (ABP), Apollomics (APLM), Citius Pharmaceuticals (CTXR), and Synlogic (SYBX). These companies are all part of the "pharmaceutical products" industry. Alaunos Therapeutics vs. Its Competitors Clearside Biomedical Synaptogenix Hoth Therapeutics Lunai Bioworks Reviva Pharmaceuticals Cingulate Abpro Apollomics Citius Pharmaceuticals Synlogic Clearside Biomedical (NASDAQ:CLSD) and Alaunos Therapeutics (NASDAQ:TCRT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Which has more risk & volatility, CLSD or TCRT? Clearside Biomedical has a beta of 2.05, suggesting that its stock price is 105% more volatile than the S&P 500. Comparatively, Alaunos Therapeutics has a beta of -0.84, suggesting that its stock price is 184% less volatile than the S&P 500. Is CLSD or TCRT more profitable? Alaunos Therapeutics has a net margin of 0.00% compared to Clearside Biomedical's net margin of -665.19%. Clearside Biomedical's return on equity of 0.00% beat Alaunos Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Clearside Biomedical-665.19% N/A -124.15% Alaunos Therapeutics N/A -168.02%-121.37% Do analysts rate CLSD or TCRT? Clearside Biomedical currently has a consensus price target of $63.00, suggesting a potential upside of 1,482.91%. Given Clearside Biomedical's stronger consensus rating and higher probable upside, analysts plainly believe Clearside Biomedical is more favorable than Alaunos Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearside Biomedical 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17Alaunos Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has higher earnings & valuation, CLSD or TCRT? Alaunos Therapeutics has lower revenue, but higher earnings than Clearside Biomedical. Alaunos Therapeutics is trading at a lower price-to-earnings ratio than Clearside Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearside Biomedical$4.17M5.00-$34.35M-$5.55-0.72Alaunos Therapeutics$10K769.08-$4.68M-$2.46-1.41 Do insiders and institutionals have more ownership in CLSD or TCRT? 18.8% of Clearside Biomedical shares are held by institutional investors. Comparatively, 27.7% of Alaunos Therapeutics shares are held by institutional investors. 6.7% of Clearside Biomedical shares are held by insiders. Comparatively, 16.1% of Alaunos Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media refer more to CLSD or TCRT? In the previous week, Clearside Biomedical had 1 more articles in the media than Alaunos Therapeutics. MarketBeat recorded 3 mentions for Clearside Biomedical and 2 mentions for Alaunos Therapeutics. Clearside Biomedical's average media sentiment score of 1.10 beat Alaunos Therapeutics' score of 0.96 indicating that Clearside Biomedical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearside Biomedical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alaunos Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryClearside Biomedical beats Alaunos Therapeutics on 9 of the 16 factors compared between the two stocks. Get Alaunos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TCRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCRT vs. The Competition Export to ExcelMetricAlaunos TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.69M$2.59B$6.01B$10.24BDividend YieldN/A56.68%5.66%4.69%P/E Ratio-1.4122.9185.3526.57Price / Sales769.08612.53583.18179.21Price / CashN/A177.3038.3262.20Price / Book2.705.3712.726.53Net Income-$4.68M$32.78M$3.30B$275.96M7 Day Performance35.94%2.39%1.04%-1.40%1 Month Performance58.90%10.26%7.56%5.16%1 Year Performance57.47%-0.21%79.68%31.55% Alaunos Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCRTAlaunos Therapeutics1.177 of 5 stars$3.48-12.8%N/A+81.4%$7.69M$10K-1.4140Short Interest ↓Gap DownCLSDClearside Biomedical2.9511 of 5 stars$3.97-5.5%$63.00+1,486.9%-77.8%$21.99M$1.66M-0.7230Positive NewsTAOXSynaptogenix0.1842 of 5 stars$6.55+4.3%N/AN/A$21.90MN/A-0.324News CoverageAnalyst ForecastGap UpHOTHHoth Therapeutics1.9994 of 5 stars$1.62-1.8%$4.00+146.9%+109.9%$21.88MN/A-1.514News CoverageAnalyst ForecastRENBLunai Bioworks0.7165 of 5 stars$1.42+12.2%N/A-63.3%$21.79MN/A-1.8420Positive NewsGap DownRVPHReviva Pharmaceuticals3.6496 of 5 stars$0.37+19.6%$4.86+1,217.7%-28.6%$21.38MN/A-0.575Analyst ForecastGap DownHigh Trading VolumeCINGCingulate2.5144 of 5 stars$3.92+0.8%$26.25+569.6%+0.2%$21.06MN/A-0.9620News CoverageAnalyst ForecastABPAbpro3.2677 of 5 stars$0.22-12.7%$4.00+1,684.1%N/A$20.59M$180K0.0015Analyst ForecastAPLMApollomics0.7624 of 5 stars$18.43+51.3%N/A+36.4%$20.34M$1.49M0.0045Analyst ForecastGap UpHigh Trading VolumeCTXRCitius Pharmaceuticals2.6684 of 5 stars$1.24+5.1%$53.00+4,174.2%-86.9%$20.07MN/A0.0020Analyst ForecastGap UpSYBXSynlogic0.7144 of 5 stars$1.68-1.2%N/A+17.1%$19.89MN/A-21.0080News CoveragePositive NewsAnalyst ForecastGap Down Related Companies and Tools Related Companies Clearside Biomedical Alternatives Synaptogenix Alternatives Hoth Therapeutics Alternatives Lunai Bioworks Alternatives Reviva Pharmaceuticals Alternatives Cingulate Alternatives Abpro Alternatives Apollomics Alternatives Citius Pharmaceuticals Alternatives Synlogic Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TCRT) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
